Biolife Solutions INC 10-Q quarterly reports

BioLife Solutions announced a significant merger agreement with Repligen Corporation, alongside reporting a 21% year-over-year revenue increase for the second quarter of 2026.

BioLife Solutions posted a 31% revenue increase in Q3 2025, returning to net income while strategically divesting non-core assets and acquiring new cryopreservation technology.

BioLife Solutions reported a 29% revenue increase in Q2 2025, driven by strong cell processing and thawing product demand, alongside a widened net loss due to a $15.5 million R&D expense from the PanTHERA acquisition.

BioLife Solutions saw a 30% increase in revenue in Q1 2025, primarily driven by higher demand for its cell processing products.

BioLife Solutions reports a 30% increase in total revenue for the third quarter of 2024 compared to the same period last year, driven by strong growth in cell processing product sales.

BioLife Solutions' Q2 2024 results show a decrease in revenue and a net loss, impacted by customer destocking and the divestiture of Global Cooling.

BioLife Solutions experienced a decrease in revenue for the first quarter of 2024, alongside the strategic divestiture of its Global Cooling subsidiary.